Quanthealth

QuantHealth is a clinical trial simulation platform for pharmaceutical and biotech companies. Its foundation model, trained on more than 100 million patient records and validated across more than 600 completed clinical trials, simulates how diverse real world patients would respond to an investigational therapy, so that trial design, portfolio and commercial decisions rest on predicted outcomes rather than historical landscapes. The company's own comparison overlays simulated and actual survival curves for a multiple myeloma trial to show how closely the simulation tracks reality. It serves clinical development, business development, portfolio management and competitive intelligence teams at drug developers. The Predictive Competitive Positioning solution forecasts trial level and subpopulation outcomes for both a sponsor's asset and competing Phase 2 and Phase 3 programs, with no sponsor data required for competitors, and simulates head to head comparisons across biomarkers, patient segments and market segments. Use cases published by the company include designing trials with better enrollment feasibility and differentiation, sizing market potential before a patient is enrolled, and supporting go or no go licensing decisions. The underlying data framework integrates biomedical, clinical and epidemiological sources covering 350 million lives. Pricing is not published. QuantHealth sells through enterprise agreements, and prospective customers request a demo or an evidence review through the contact form on the site. The company is headquartered in Worcester, Massachusetts, with a second office in Tel Aviv.